Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

April 28, 2023 00:27:21
Episode Cover

Should We Add Fludrocortisone to Hydrocortisone for Septic Shock?

The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the...

Listen

Episode 0

March 08, 2021 00:28:05
Episode Cover

COVID-19 Updates March 2021

In recent weeks, there have been several important studies and guidelines published that have served to improve our understanding of treating critically ill patients...

Listen

Episode 0

September 11, 2018 00:24:03
Episode Cover

Bicarbonate for Severe Acidosis?

Many critically ill patients are acidotic.  Often, bicarbonate is administered to severely acidotic patients, but does it really improve outcomes?  The BICAR-ICU was just...

Listen